A Win For TransCode Therapeutics Inc.
Thu, Jan 23, 2025 at 07:30 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) jumped higher at $5.5, a gain of 57.1%. On Thu, Jan 23, 2025, RNAZ:NASDAQ hit a New 2-Week High of $5.5. The stock got featured on our News Catalysts scanner on Tue, Jan 14, 2025 at 09:25 AM in the 'BIOTECH' category. From Fri, Jan 10, 2025, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Thu, Jan 23, 2025 at $12.43 with a volume of 10M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Dogwood Therapeutics Inc. (DWTX:NASDAQ), 376.79%
- Diginex Limited (DGNX:NASDAQ), 70%
- Vince Holding Corp. (VNCE:NYSE), 65.96%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 57.14%
- CTRL Group Limited (MCTR:NASDAQ), 56.81%
- Evaxion Biotech A/S (EVAX:NASDAQ), 52.94%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 48.15%
- N2OFF Inc. (NITO:NASDAQ), 45.34%
- Lightbridge Corporation (LTBR:NASDAQ), 41.11%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%